drugset / Trial / NCT02096107

Novartis Everolimus Transition

NCT02096107

RandomizedParallel-groupOpen-labelTreatment

Summary

Transition from tacrolimus based triple therapy with Mycophenolate Mofetil (MMF) and steroids in stable renal transplant patients to low intensity tacrolimus, everolimus and prednisone will be associated with improvement in Glomular Filtration Rate (GFR) and allograft fibrosis.

Timeline

Start
2014-02
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Everolimus Small molecule